GGrantIndex
← Leaderboards

Ying Xian

Ut Southwestern Medical Center

$6,460,808
Attributed
$6,460,808
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY201925
$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,460,808 · 3

By mechanism

R01$6,460,808 · 3

Top collaborators

No co-investigators on record.

Most similar at Ut Southwestern Medical Center

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Patient Oriented

Research focus

Patient OrientedRecurrenceIschemic StrokeMissionPharmaceutical PreparationsPublic HealthHospitalsInnovationDatabasesLinkGuidelinesClinical TrialsAmericanPreventAmerican Heart AssociationHeterogeneityAgingClinical PracticeBurden Of IllnessComorbidityCardiovascular DiseasesEventAdoptionRegistries

Grant awards (12)

Post-stroke Cognitive Impairment and Dementia$795,304
R01 · FY2025 · AG · contact PI
Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation$471,127
R01 · FY2025 · AG · contact PI
Post-stroke Cognitive Impairment and Dementia$834,094
R01 · FY2024 · AG · contact PI
Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation$494,276
R01 · FY2024 · AG · contact PI
Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)$302,654
R01 · FY2023 · AG · contact PI
Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation$493,248
R01 · FY2022 · AG · contact PI
Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)$390,202
R01 · FY2022 · AG · contact PI
Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation$567,718
R01 · FY2021 · AG · contact PI
Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)$509,566
R01 · FY2021 · AG · contact PI
Balancing Risks and Benefits of Direct Oral Anticoagulants in Older Ischemic Stroke Patients with Atrial Fibrillation$576,918
R01 · FY2020 · AG · contact PI
Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)$515,169
R01 · FY2020 · AG · contact PI
Antiplatelet in Stroke: Safety and Effectiveness in Seniors (ASSESS)$510,532
R01 · FY2019 · AG · contact PI